Usefulness of assessment of circulating tumor DNA(ctDNA) of cerebrospinal fluid(CSF) samples for early detection of brain metastasis (BrM) in patients with triple-negative breast cancer (TNBC).

被引：0
|
作者：
Raimondi, Lucrezia
Naso, Giuseppe
Lazzeroni, Rachele
Di Benedetto, Laura
Raimondi, Filippo Maria
Di Rocco, Arianna
Giaconi, Laura
Rossi, Luigi
Spinelli, Gian Paolo
机构：
[1] Sapienza Univ Rome, UOC Terr Oncol Aprilia, Aprilia, Italy
[2] Policlin Umberto 1, Div Med Oncol, Rome, Italy
[3] Sapienza Univ Rome, Dept Med & Surg Sci & Translat Med, St Andrea Univ Hosp, Rome, Italy
[4] BIOS SpA, Rome, Italy
[5] E Campus Univ, Rome, Italy
[6] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy
[7] Sapienza Univ Rome, Clin & Mol Med Dept, Rome, Italy
[8] Sapienza Univ Rome, OC Terr Oncol Aprilia, AUSL Latina, Aprilia, Italy
[9] Sapienza Univ Rome, AUSL Latina, UOC Terr Oncol Aprilia, Aprilia, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
507
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Potential predictive value of circulating tumor DNA (ctDNA) mutations for the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer
    Tan, Qiaorui
    Chi, Yajing
    Su, Mu
    Zhou, Jinxing
    Zhou, Dongdong
    Zheng, Fangchao
    Man, Xiaochu
    Sun, Shujuan
    Huang, Jie
    Li, Huihui
    FRONTIERS IN GENETICS, 2023, 14
  • [22] Targeting brain metastasis from triple-negative breast cancer by blocking CSF1R signaling in the tumor microenvironment
    Zhang, W.
    Rahman, S.
    Isanogle, K.
    Kumar, D.
    Wu, A.
    Wei, D.
    Fujii, T.
    Difilippantonio, S.
    Steeg, P.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S45 - S45
  • [23] Utility of circulating tumor DNA (ctDNA) from cerebrospinal fluid (CSF) for prognosis of patients with recurrent high grade glioma
    Holle, Bridget M.
    Nandakumar, Subhiksha
    Kreitzer, Christoph
    Song, Timothy
    Tartaro, Marlene
    Hertz, Charli Ann J.
    Rafailov, Johnathan
    Campos, Carl
    Reiner, Anne S.
    Young, Robert
    Meng, Alicia
    Pasquini, Luca
    Brannon, A. Rose
    Socci, Nicholas D.
    Arcila, Maria E.
    Solit, David B.
    Berger, Michael F.
    Schultz, Nikolaus
    Mellinghoff, Ingo K.
    Miller, Alexandra M.
    CANCER RESEARCH, 2024, 84 (06)
  • [24] Co-detection of circulating tumor DNA and RNA for enhanced detection of minimal residual disease in patients with chemorefractory triple-negative breast cancer
    Chen, Yu-Hsiang
    Hancock, Bradley A.
    Solzak, Jeffrey P.
    Schneider, Bryan P.
    Miller, Kathy D.
    Radovich, Milan
    CANCER RESEARCH, 2020, 80 (16)
  • [25] FAK is Required for Tumor Metastasis-Related Fluid Microenvironment in Triple-Negative Breast Cancer
    Pan, Mei-Ren
    Hou, Ming-Feng
    Ou-Yang, Fu
    Wu, Chun-Chieh
    Chang, Shu-Jyuan
    Hung, Wen-Chun
    Yip, Hon-Kan
    Luo, Chi-Wen
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (01)
  • [26] Peripheral immune subsets and circulating tumor DNA (ctDNA) in patients (pts) with residual triple negative breast cancer (TNBC) treated with adjuvant immunotherapy and/or chemotherapy (chemo): The OXEL study
    Lynce, Filipa
    Mainor, Candace
    Geng, Xue
    Jones, Greg
    Schlam, Ilana
    Wang, Hongkun
    Feger, Ute
    Donahue, Renee
    Toney, Nicole
    Jochems, Caroline
    Schlom, Jeffrey
    Gallagher, Christopher
    Nanda, Rita
    Graham, Deena
    Stringer-Reasor, Erica M.
    Denduluri, Neelima
    Collins, Julie
    Dilawari, Asma A.
    Chitalia, Ami
    Tiwari, Shruti
    Nunes, Raquel
    Kaltman, Rebecca
    Khoury, Katia
    Gatti-Mays, Margaret
    Swain, Sandra M.
    Parsons, Heather A.
    Pohlmann, Paula
    Isaacs, Claudine
    CANCER RESEARCH, 2022, 82 (04)
  • [27] Effect of cabozantinib treatment on circulating immune cell populations in patients with metastatic triple-negative breast cancer (TNBC).
    Duda, Dan G.
    Ziehr, David R.
    Guo, Hao
    Ng, Mei
    Barry, William Thomas
    Higgins, Michaela Jane
    Isakoff, Steven J.
    Brock, Jane E.
    Ivanova, Elena
    Paweletz, Cloud
    Demeo, Michelle
    Ramaiya, Nikhil H.
    Overmoyer, Beth
    Jain, Rakesh K.
    Winer, Eric P.
    Tolaney, Sara M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [28] Correlation of Snail expression and survival in patients with early-stage triple-negative breast cancer (TNBC)
    Jiralerspong, S.
    Liu, S.
    Palla, S. L.
    Mills, G. B.
    Hung, M.
    Hortobagyi, G. N.
    Gonzalez-Angulo, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] Detection of circulating tumor DNA (ctDNA) after neoadjuvant chemotherapy is significantly associated with disease recurrence in early-stage triple-negative breast cancer (TNBC): Preplanned correlative results from clinical trial BRE12-158
    Radovich, Milan
    Jiang, Guanglong
    Chitambar, Christopher
    Nanda, Rita
    Falkson, Carla
    Lynce, Filipa C.
    Gallagher, Christopher
    Isaacs, Claudine
    Blaya, Marcelo
    Paplomata, Elisavet
    Walling, Radhika
    Daily, Karen
    Mahtani, Reshma
    Thompson, Michael A.
    Graham, Robert
    Cooper, Maureen E.
    Pavlick, Dean C.
    Albacker, Lee
    Gregg, Jeff
    Bales, Casey L.
    Hancock, Bradley A.
    Cantor, Erica
    Shen, Fei
    Storniolo, Anna Maria V.
    Badve, Sunil
    Ballinger, Tarah
    Miller, Kathy D.
    Schneider, Bryan P.
    CANCER RESEARCH, 2020, 80 (04)
  • [30] Prognostic Implications of Cerebrospinal Fluid Circulating Tumor DNA (CSF ctDNA) Following Radiation Therapy in Patients with Leptomeningeal Metastasis: Analysis of a Randomized Phase II Trial
    Goglia, A. G.
    Yang, J. T.
    Kratochvil, L. B.
    Yerramilli, D.
    Higginson, D. S.
    Miller, A.
    Berger, M.
    Powell, S. N.
    Boire, A.
    Wijetungah, N. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S69 - S70
12345